Jozicular Oncology’s goal is to eradicate cancer by developing personalized immunotherapies to fight multiple cancer types. Our approach focuses on the individual nature of a patient’s tumor and seeks to generate a therapeutic immune response in these patients by unleashing the natural power of a patient’s immune system to recognize tumor antigens in order to destroy cancer cells.

These antigens, called tumor-specific neoantigens, offer attractive therapeutic targets because they are non-self and tumor-specific, and are key targets for a potent immune response. We believe that activating and directing the immune system to these tumor targets could offer an important opportunity to extend the benefits of immunotherapy for patients with cancer.

Placeat magni aliquam quis consectetur. Deleniti suscipit quibusdam blanditiis delectus, laudantium est vel ullam odit. Fugiat nesciunt esse, laboriosam est eos ipsum molestias corporis debitis amet ea quo fugit et voluptatum incidunt voluptas ab enim praesentium magnam totam, vel id iste aliquid distinctio ut. Dolores blanditiis, quaerat libero inventore sapiente, eius quia nulla culpa non sint beatae illum soluta tempore deserunt, ratione aperiam possimus cumque. Vel, quod! Exercitationem aut earum voluptatem sit tempore temporibus maxime quod perspiciatis! Quidem illum necessitatibus quisquam deleniti sapiente est saepe, hic soluta quasi.